Literature DB >> 19647494

Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects.

Alan R Light1, Andrea T White, Ronald W Hughen, Kathleen C Light.   

Abstract

UNLABELLED: Chronic fatigue syndrome (CFS) is characterized by debilitating fatigue, often accompanied by widespread muscle pain that meets criteria for fibromyalgia syndrome (FMS). Symptoms become markedly worse after exercise. Previous studies implicated dysregulation of the sympathetic nervous system (SNS), and immune system (IS) in CFS and FMS. We recently demonstrated that acid sensing ion channel (probably ASIC3), purinergic type 2X receptors (probably P2X4 and P2X5) and the transient receptor potential vanilloid type 1 (TRPV1) are molecular receptors in mouse sensory neurons detecting metabolites that cause acute muscle pain and possibly muscle fatigue. These molecular receptors are found on human leukocytes along with SNS and IS genes. Real-time, quantitative PCR showed that 19 CFS patients had lower expression of beta-2 adrenergic receptors but otherwise did not differ from 16 control subjects before exercise. After a sustained moderate exercise test, CFS patients showed greater increases than control subjects in gene expression for metabolite detecting receptors ASIC3, P2X4, and P2X5, for SNS receptors alpha-2A, beta-1, beta-2, and COMT and IS genes for IL10 and TLR4 lasting from 0.5 to 48 hours (P < .05). These increases were also seen in the CFS subgroup with comorbid FMS and were highly correlated with symptoms of physical fatigue, mental fatigue, and pain. These new findings suggest dysregulation of metabolite detecting receptors as well as SNS and IS in CFS and CFS-FMS. PERSPECTIVE: Muscle fatigue and pain are major symptoms of CFS. After moderate exercise, CFS and CFS-FMS patients show enhanced gene expression for receptors detecting muscle metabolites and for SNS and IS, which correlate with these symptoms. These findings suggest possible new causes, points for intervention, and objective biomarkers for these disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647494      PMCID: PMC2757484          DOI: 10.1016/j.jpain.2009.06.003

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  78 in total

Review 1.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect--possible role of peripheral tissues.

Authors:  R Staud; C J Vierck; M E Robinson; D D Price
Journal:  Rheumatology (Oxford)       Date:  2006-04-18       Impact factor: 7.580

3.  A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.

Authors:  Björn de Rijke; Agnes van Horssen-Zoetbrood; Jeffrey M Beekman; Britt Otterud; Frans Maas; Rob Woestenenk; Michel Kester; Mark Leppert; Anton V Schattenberg; Theo de Witte; Elly van de Wiel-van Kemenade; Harry Dolstra
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 4.  A review of the evidence for overlap among unexplained clinical conditions.

Authors:  L A Aaron; D Buchwald
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

5.  Gene expression profile of empirically delineated classes of unexplained chronic fatigue.

Authors:  Liran Carmel; Sol Efroni; Peter D White; Eric Aslakson; Ute Vollmer-Conna; Mangalathu S Rajeevan
Journal:  Pharmacogenomics       Date:  2006-04       Impact factor: 2.533

Review 6.  Fibromyalgia: a disorder of the brain?

Authors:  Petra Schweinhardt; Khara M Sauro; M Catherine Bushnell
Journal:  Neuroscientist       Date:  2008-02-12       Impact factor: 7.519

7.  Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism.

Authors:  Michael E Geisser; Cathy Strader Donnell; Frank Petzke; Richard H Gracely; Daniel J Clauw; David A Williams
Journal:  Psychosomatics       Date:  2008 May-Jun       Impact factor: 2.386

8.  Identification of marker genes for differential diagnosis of chronic fatigue syndrome.

Authors:  Takuya Saiki; Tomoko Kawai; Kyoko Morita; Masayuki Ohta; Toshiro Saito; Kazuhito Rokutan; Nobutaro Ban
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

9.  Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis.

Authors:  Ingrid M Overes; Björn de Rijke; Agnes van Horssen-Zoetbrood; Hanny Fredrix; Aniek O de Graaf; Joop H Jansen; J Han J M van Krieken; Reinier A P Raymakers; Robbert van der Voort; Theo M de Witte; Harry Dolstra
Journal:  Br J Haematol       Date:  2008-04-10       Impact factor: 6.998

10.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jonathan R Kerr; Robert Petty; Beverley Burke; John Gough; David Fear; Lindsey I Sinclair; Derek L Mattey; Selwyn C M Richards; Jane Montgomery; Don A Baldwin; Paul Kellam; Tim J Harrison; George E Griffin; Janice Main; Derek Enlander; David J Nutt; Stephen T Holgate
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

View more
  72 in total

1.  Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Authors:  L V Clark; M Buckland; G Murphy; N Taylor; V Vleck; C Mein; E Wozniak; M Smuk; P D White
Journal:  Clin Exp Immunol       Date:  2017-10-11       Impact factor: 4.330

2.  Minimum data elements for research reports on CFS.

Authors:  Leonard A Jason; Elizabeth R Unger; Jordan D Dimitrakoff; Adam P Fagin; Michael Houghton; Dane B Cook; Gailen D Marshall; Nancy Klimas; Christopher Snell
Journal:  Brain Behav Immun       Date:  2012-01-28       Impact factor: 7.217

Review 3.  Rise of the sensors: nociception and pruritus.

Authors:  James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 4.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

Review 5.  ASIC3 channels in multimodal sensory perception.

Authors:  Wei-Guang Li; Tian-Le Xu
Journal:  ACS Chem Neurosci       Date:  2010-11-12       Impact factor: 4.418

Review 6.  Significance of Group III and IV muscle afferents for the endurance exercising human.

Authors:  Markus Amann
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-09       Impact factor: 2.557

7.  Avoidance behavior towards physical activity in chronic fatigue syndrome and fibromyalgia: the fear for post-exertional malaise.

Authors:  Jo Nijs; Mari Lundberg
Journal:  Clin Rheumatol       Date:  2013-11-07       Impact factor: 2.980

8.  Prefrontal lactate predicts exercise-induced cognitive dysfunction in Gulf War Illness.

Authors:  Rakib U Rayhan; Megna P Raksit; Christian R Timbol; Oluwatoyin Adewuyi; John W Vanmeter; James N Baraniuk
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

9.  Problems in defining post-exertional malaise.

Authors:  Leonard A Jason; Meredyth Evans; Suzanna So; Jilian Scott; Abigail Brown
Journal:  J Prev Interv Community       Date:  2015

10.  Evidence for a heritable predisposition to Chronic Fatigue Syndrome.

Authors:  Frederick Albright; Kathleen Light; Alan Light; Lucinda Bateman; Lisa A Cannon-Albright
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.